Purpose Of Review: The current review discusses allergen immunotherapy (AIT) safety in children.
Recent Findings: AIT is a well tolerated and effective treatment for pediatric allergic conditions. While mostly well tolerated, severe reactions and near fatal reactions may occur with subcutaneous immunotherapy (SCIT) once in every 160 000 visits.